Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.74B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.61B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.02B |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.54B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.5B |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$639M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$552M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.13% |
| 2 | Financials | 8.44% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Healthcare | 7.43% |
| 5 | Industrials | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5201
Brilliant Earth
BRLT
$17.2M
| $90.1K | ﹤0.01% |
24,227
-3,443
| -12% | -$9.9K |
|
|
AEVA
5202
Aeva Technologies
AEVA
$1.4B
| $89.8K | ﹤0.01% |
23,699
+1,750
| +8% | +$5.59K |
|
|
EGIO
5203
DELISTED
Edgio, Inc. Common Stock
EGIO
| $89.1K | ﹤0.01% |
6,506
-249
| -4% | -$6.14K |
|
|
API
5204
Agora
API
$345M
| $88.9K | ﹤0.01% |
33,799
-597
| -2% | -$1.67K |
|
|
SLI
5205
Standard Lithium
SLI
$539M
| $88.5K | ﹤0.01% |
+43,813
| New | +$109K |
|
5206
Citizens
CIA
$233M
| $88K | ﹤0.01% |
+32,723
| New | +$101K |
|
5207
AC Immune
ACIU
$231M
| $86.5K | ﹤0.01% |
+17,290
| New | +$55.6K |
|
5208
Vor Biopharma
VOR
$1.21B
| $86.3K | ﹤0.01% |
1,917
+639
| +50% | +$26.4K |
|
|
SOL
5209
DELISTED
Emeren Group
SOL
| $86.2K | ﹤0.01% |
31,565
-6,816
| -18% | -$18K |
|
5210
Veritone
VERI
$112M
| $85.3K | ﹤0.01% |
47,140
-2,729
| -5% | -$6.08K |
|
|
NYXH
5211
Nyxoah
NYXH
$143M
| $84.5K | ﹤0.01% |
18,208
-39,559
| -68% | -$217K |
|
|
NEWP
5212
New Pacific Metals
NEWP
$964M
| $83.9K | ﹤0.01% |
43,924
+26,398
| +151% | +$45.6K |
|
5213
Lifezone Metals Ltd Warrants
LZM.WS
$21.4M
| $83.7K | ﹤0.01% |
156,400
| – | – |
|
|
LBPH
5214
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $82.6K | ﹤0.01% |
13,699
+2,626
| +24% | +$13.1K |
|
|
KG
5215
Kestrel Group
KG
$74.3M
| $82.2K | ﹤0.01% |
1,796
-564
| -24% | -$20.9K |
|
5216
Shengfeng Development Ltd
SFWL
$74.2M
| $81.4K | ﹤0.01% |
+27,693
| New | +$309K |
|
5217
Unicycive Therapeutics
UNCY
$140M
| $81K | ﹤0.01% |
9,334
+11
| +0.1% | +$72 |
|
|
LILM
5218
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $80.3K | ﹤0.01% |
68,012
+43,618
| +179% | +$39.7K |
|
|
PPTA
5219
Perpetua Resources
PPTA
$2.61B
| $79.7K | ﹤0.01% |
25,128
-1,414
| -5% | -$4.77K |
|
|
PHLT
5220
DELISTED
Performant Healthcare Inc
PHLT
| $79.6K | ﹤0.01% |
25,467
+97
| +0.4% | +$254 |
|
5221
Eos Energy Enterprises
EOSE
$1.58B
| $79.5K | ﹤0.01% |
72,913
+9,238
| +15% | +$13.5K |
|
5222
Actinium Pharmaceuticals
ATNM
$26M
| $78.6K | ﹤0.01% |
15,480
-30,864
| -67% | -$159K |
|
|
GPGI
5223
GPGI Inc
GPGI
$4.54B
| $77.4K | ﹤0.01% |
17,268
-245
| -1% | -$1.14K |
|
5224
Enel Chile
ENIC
$6.35B
| $74.8K | ﹤0.01% |
+23,079
| New | +$71.8K |
|
|
LENZ
5225
LENZ Therapeutics
LENZ
$156M
| $74.8K | ﹤0.01% |
4,077
-749
| -16% | -$12.4K |
|
Similar funds
Goldman Sachs's Q4 2023 Portfolio in Review
As of Q4 2023, Goldman Sachs held 6,018 positions worth $543B, up 15% from $470B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs deployed $17.8B of net new capital in Q4 2023, opening 537 new positions and adding to 2,390 existing holdings. Its largest new stake was Goldman Sachs MarketBeta Russell 1000 Value Equity ETF: 9,747,656 shares worth $415M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $1.58B trimmed.
- Goldman Sachs's largest Q4 2023 buy was Goldman Sachs MarketBeta Russell 1000 Value Equity ETF: 9,747,656 shares worth $415M.
- Goldman Sachs added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $2.74B increase.
- Goldman Sachs's biggest Q4 2023 reduction was Apple, cutting an estimated $1.58B.
- Goldman Sachs fully exited Activision Blizzard in Q4 2023, selling an estimated $639M.
- Goldman Sachs's ten largest holdings make up 18% of its $543B portfolio in Q4 2023.
- Goldman Sachs opened 537 new positions and closed 416 in Q4 2023.
- Goldman Sachs's portfolio value rose 15% quarter-over-quarter to $543B.
Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.